Dr. Meyer is Delix’s Head of Corporate Strategy and provides both strategic and operational leadership for business development, asset and IP strategy, fundraising and investor relations, competitive intelligence, and diligence and deal execution. In addition, Dr. Meyer is a key driver for building and shaping corporate structures and for cultivating a productive company culture where employees can thrive. Dr. Meyer is a translational neuroscientist by training and an entrepreneur by profession. Her mission is to galvanize the era of precision medicine for brain health. To that end, she has been founder, advisor, or early employee in several startups and biotech’s working to develop or support objective diagnostics or personalized therapeutics for neurology. Before Delix, Dr. Meyer worked as an Entrepreneur-in-Residence (EIR) for hire working with VCs, Startups, and Academic Entrepreneurs as a trusted scientific advisor, strategy consultant, and transitional leader to translate visionary science to commercial endeavors. She serves on the Board of the Museum of Science, Boston, and the Advisory Boards for PYM, Inc and Concerto Bio. She has her PhD in Neuroscience and Neuroendocrinology from MIT, was a Fulbright Fellow at NTNU in the Moser lab (2014 Nobel in Medicine) and graduated from the University of Arizona with degrees in Mathematics, Biochemistry & Molecular Biophysics, and Biopsychology.